Exicure Operating Co.

Exicure Operating Co.

Exicure Operating Co.

Overview
Headquarters

8045 LAMON AVENUE SUITE 410 SKOKIE IL 60077

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Pharmaceuticals
Biotechnology

Company Description

Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL.

Executives & Employees

Chief Executive Officer

Chief Operating Officer

Vice President, Head of Business Development

Director Program Management

Manager

Professional

Professional

Professional

Professional

Professional

Board of Directors

President, Chief Executive Officer & Director at Angion Biomedica Corp.

Former Professional at Exicure Operating Co.

Chief Executive Officer, Secretary & Director at Exicure, Inc.

Chairman, President & Chief Executive Officer at Horizon Therapeutics Plc

Board Overseer at Harvard University - Beth Israel Deaconess Medical Center at Harvard Medical School

Managing Partner at Abingworth LLP

President & Chief Executive Officer at Ilypsa, Inc.

Paths to Exicure Operating Co.
Potential Connections via
Relationship Science
You
Exicure Operating Co.
Recent Transactions
Details Hidden

Max 1 Acquisition Corp. purchases Exicure Operating Co. from AbbVie Ventures resulting in a new company Exicure, Inc.

Details Hidden

Exicure Operating Co. raised money in a private placement transaction

Details Hidden

Exicure Operating Co. raised money in a private placement transaction

Transaction Advisors
Legal Advisor

Advised onMax 1 Acquisition Corp. purchases Exicure Operating Co. from AbbVie Ventures resulting in a new company Exicure, Inc.

Legal Advisor

Advised onMax 1 Acquisition Corp. purchases Exicure Operating Co. from AbbVie Ventures resulting in a new company Exicure, Inc.

Investors
Details Hidden

Chief Executive Officer & Chairman of the Board at Ryan Specialty Group Holdings, Inc.

Details Hidden

Science & Technology Advisory Council at Government of the United States of America

Details Hidden

Co-Founder at Quanterix Corp.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Exicure Operating Co.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Exicure Operating Co.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Exicure Operating Co..